EP 0752879 A1 19970115 - TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
Title (en)
TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
Title (de)
BEHANDLUNG VON AUTOIMMUN-KRANKHEITEN MITTELS ORALER TOLERIERUNG UND/ODER TH2-ERHÖHENDEN CYTOKINEN
Title (fr)
TRAITEMENT DE MALADIES AUTO-IMMUNES AVEC DES AGENTS D'INDUCTION DE TOLERANCE ET/OU DES CYTOKINES DE RENFORCEMENT DES Th2 ADMINISTRES PAR VOIE ORALE
Publication
Application
Priority
- US 9504512 W 19950407
- US 22537294 A 19940408
- US 33252494 A 19941031
Abstract (en)
[origin: WO9527500A1] The invention is directed to methods for treating autoimmune diseases such as multiple sclerosis by orally administering a bystander antigen such as myelin basic protein or proteolipid protein in conjunction with a non-interferon polypeptide having Th2-enhancing cytokine activity in such a manner as to induce oral tolerance to the bystander antigen resulting in suppression of the autoimmune response.
IPC 1-7
A61K 38/17; A61K 38/19; A61K 38/20; A61K 38/26; A61K 38/28; A61K 38/39
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 38/20 (2006.01); A61K 38/26 (2006.01); A61K 38/28 (2006.01); A61K 38/39 (2006.01); A61K 38/43 (2006.01); A61K 39/00 (2006.01); A61P 3/08 (2006.01); A61P 3/10 (2006.01); A61P 13/02 (2006.01); A61P 15/00 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01); C07K 14/47 (2006.01)
CPC (source: EP KR)
A61K 38/19 (2013.01 - KR); A61K 38/20 (2013.01 - KR); A61K 38/2026 (2013.01 - EP); A61K 38/26 (2013.01 - KR); A61K 38/39 (2013.01 - EP KR); A61K 39/00 (2013.01 - KR); A61K 39/0008 (2013.01 - EP); A61P 3/08 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); C07K 14/4713 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9527500 A1 19951019; AU 2246795 A 19951030; AU 695883 B2 19980827; BR 9507452 A 19970805; CA 2187345 A1 19951019; EP 0752879 A1 19970115; EP 0752879 A4 19990721; HU 9602751 D0 19961128; HU T76101 A 19970630; IL 113301 A0 19950731; JP H09511990 A 19971202; KR 970702067 A 19970513; NO 964200 D0 19961003; NO 964200 L 19961003
DOCDB simple family (application)
US 9504512 W 19950407; AU 2246795 A 19950407; BR 9507452 A 19950407; CA 2187345 A 19950407; EP 95915653 A 19950407; HU 9602751 A 19950407; IL 11330195 A 19950407; JP 52652295 A 19950407; KR 19960705596 A 19961007; NO 964200 A 19961003